Developing vaccines for infectious diseases including SARS-CoV-2
Official title: V25: PROCESS DEVELOPMENT FOR VACCINE CANDIDATES INCLUDING SARS-COV-2
Funded at International AIDS Vaccine Initiative · NIH-10168830 · Data updated 2026-11-12
This study is working on creating new vaccines to help protect people from serious infections, especially those that could be used in bioterrorism or are coming back, so that patients can have better options for staying healthy.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | International AIDS Vaccine Initiative NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | May 15, 2018 |
| Project end | May 14, 2028 |
| Funding year | 2020 |
| Award (this year) | $20,264 |
| NIH project number | 272201800010I-0-759302000001-1 |
| Project ID | NIH-10168830 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include individuals at risk for infectious diseases, particularly those related to bioterrorism or emerging infections.
✕Less likely to help
Patients who are not at risk for infectious diseases or those who have already been vaccinated against the specific pathogens being targeted may not receive benefit from this research.
What this research studies
This research focuses on the development and manufacturing of vaccines and biologics aimed at combating infectious diseases, particularly those that pose a threat of bioterrorism or are emerging and re-emerging. The project includes planning and feasibility assessments, product optimization, and compliance with regulatory standards for clinical studies. Patients may benefit from the development of new vaccines that could protect against serious infections. The research also involves the production of vaccine components and delivery systems.
Why it matters
Potential benefit: If successful, this research could lead to the introduction of effective vaccines that protect against infectious diseases, improving public health outcomes.
How similar studies have gone: Other research has shown success in developing vaccines for infectious diseases using similar methodologies, indicating a promising approach.
Where this research is happening
-
International AIDS Vaccine Initiative
New York, United States Active
Researchers
- Principal investigator: Hassel, Thomas — International AIDS Vaccine Initiative
- Study coordinator: Hassel, Thomas
Related research
Other NIH-funded projects on the same topics.
-
How COVID-19 infection and genes may influence memory and dementia risk
This study looks at how getting COVID-19 and a person’s genes together affect the chance of developing memory problems and Alzheimer’s disease later in life.
-
Understanding flu and COVID-19 vaccine responses in people and in the lab
Researchers at Stanford explore how flu and COVID-19 vaccines work in people and in lab tests to improve protection for adults.
-
Oral small molecule inhibitors to block SARS-CoV-2 RNA replication
A Stanford-led project tests a pill that could stop SARS-CoV-2 and related viruses from copying their RNA inside infected cells.
-
Outpatient antiviral cocktails to fight SARS-CoV-2 and future RNA viruses
Researchers at Stanford are developing outpatient antiviral cocktails that could be used easily outside the hospital to treat COVID-19 and future RNA virus infections.
-
Inhibitors for SARS-CoV-2 Proteases to Block Viral Replication
A patient-facing program aims to discover and optimize small molecules that block key SARS-CoV-2 enzymes, potentially reducing viral replication.
-
How different COVID-19 vaccines shape immune responses
This project compares immune reactions after mRNA and adenoviral COVID-19 vaccines to learn how long protection lasts and why some people get breakthrough infections or side effects.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.